Chugai Pharmaceutical Co., Ltd. (CHGCY) Stock

About Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Chugai Pharmaceutical Co., Ltd. is headquartered in JP.

Chugai Pharmaceutical Co., Ltd. (CHGCY) stock trades at $22.22 with a market capitalization of $73.14B. The stock is valued at a price-to-earnings (P/E) ratio of 24.83, price-to-book of 5.77, price-to-sales of 8.72. Over the past 52 weeks the stock has ranged between $20.00 and $34.84, and currently trades 36.2% below its 52-week high.

On profitability, Chugai Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 24.02% — well above the market average, a sign of a high-quality business, return on capital employed of 30.83%, an operating margin of 47.24%, a net profit margin of 35.10%.

In its most recent fiscal year, Chugai Pharmaceutical Co., Ltd. reported annual revenue of $1.32T, net profit of $455.1B, revenue has compounded at 10.9% a year over the last five years, profit at 16.2% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.01 — a conservative balance sheet with little leverage risk, a current ratio of 4.35, total assets of $2.47T, $426.9B in cash and equivalents.

CHGCY has an average daily trading volume of 273,375 shares, a beta of 0.58 (less volatile than the overall market).

Official website: www.chugai-pharm.co.jp